# Marché des commotions cérébrales

> Informations sur le rapport de recherche sur le marché des commotions cérébrales par diagnostic et traitement (Diagnostic, Traitement), par utilisateur final (Hôpitaux et cliniques, Centres de diagnostic et payeurs) et par région (Amérique du Nord, Europe, Asie-Pacifique et reste du monde) – Prévisions du marché jusqu'en 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 5.6%
- **2024:** $ 6.34 Billion
- **2025:** $ 6.69 Billion
- **2035:** $ 11.54 Billion
- **Key Players:** Abbott Laboratories (US), Medtronic (US), Boston Scientific (US), Stryker Corporation (US), Cortech Solutions (US), Zynex Medical (US), Neurotech Pharmaceuticals (US), Huntleigh Healthcare (GB), B. Braun Melsungen AG (DE)

**Report ID:** MRFR/Pharma/4269-CR · **Pages:** 145 · **Author:** Vikita Thakur & Rahul Gotadki · **Last Updated:** September 18, 2026

**URL:** https://www.marketresearchfuture.com/reports/concussions-market-5724

---

## Market Summary

As per Market Research Future analysis, the Concussions Market Size was estimated at 6.336 USD Billion in 2024. The Concussions industry is projected to grow from 6.691 USD Billion in 2025 to 11.54 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 5.6% during the forecast period 2025 - 2035

## Market Drivers

### Advancements in Medical Technology

Technological innovations in medical devices and diagnostic tools are transforming the Concussions Market. The development of advanced imaging techniques, such as MRI and CT scans, has improved the accuracy of concussion diagnoses, enabling healthcare professionals to make informed decisions regarding treatment.
 
Furthermore, [wearable technology](https://www.marketresearchfuture.com/reports/wearable-technology-market-2336) that monitors head impacts is gaining traction, providing real-time data that can help prevent concussions. The market for these technologies is projected to grow, driven by the increasing demand for effective and efficient diagnostic solutions. As healthcare providers adopt these advancements, the overall quality of care for concussion patients is expected to improve, further propelling market growth.

### Rising Awareness of Concussion Risks

The increasing awareness surrounding the risks associated with concussions is a pivotal driver in the Concussions Market. Educational campaigns and advocacy from health organizations have heightened public consciousness about the long-term effects of concussions, particularly in contact sports. This awareness has led to a surge in demand for diagnostic tools and treatment options, as individuals seek to understand and mitigate the risks.
 
According to recent data, the prevalence of diagnosed concussions has risen significantly, indicating a growing recognition of the condition. As more individuals become informed about the potential consequences of concussions, the market is likely to expand, with a focus on innovative solutions for prevention and management.

### Increased Participation in Contact Sports

The rising participation rates in contact sports, particularly among youth, is a significant driver in the Concussions Market. As more children and adolescents engage in sports such as football, hockey, and rugby, the incidence of concussions is likely to increase. This trend has prompted schools and sports organizations to implement stricter safety protocols and concussion management programs.
 
Consequently, there is a growing demand for educational resources, training programs, and protective equipment designed to minimize the risk of concussions. The market is responding to this need by offering a variety of products aimed at enhancing player safety and promoting awareness of concussion-related issues.

### Regulatory Support for Concussion Management

Regulatory bodies are increasingly recognizing the importance of effective concussion management, which serves as a crucial driver in the Concussions Market. New guidelines and policies aimed at improving the safety of athletes have been established, mandating that organizations implement comprehensive concussion protocols.
 
This regulatory support not only enhances the safety of participants but also drives the demand for related products and services, including training programs for coaches and medical staff. As compliance with these regulations becomes essential, the market is likely to see growth in areas such as educational materials and concussion assessment tools, reflecting the commitment to athlete safety.

### Growing Investment in Research and Development

Investment in research and development within the Concussions Market is on the rise, driven by the need for innovative solutions to address the complexities of concussion management. Funding from both public and private sectors is being directed towards studies that explore the long-term effects of concussions and the efficacy of various treatment options.
 
This influx of capital is fostering the development of new therapies, diagnostic tools, and preventive measures. As research continues to unveil new insights into concussion management, the market is expected to expand, offering a wider array of products and services aimed at improving outcomes for individuals affected by concussions.

## Future Outlook

Le marché des commotions cérébrales devrait croître à un TCAC de 5,6 % de 2025 à 2035, soutenu par une sensibilisation accrue, des technologies de diagnostic avancées et des options de traitement améliorées.

**New opportunities:**

- Développement de plateformes de télésanté pour des évaluations de commotion à distance. Investissement dans des outils de diagnostic alimentés par l'IA pour une détection précoce. Expansion des programmes éducatifs ciblant les organisations sportives sur la gestion des commotions.

D'ici 2035, le marché des commotions cérébrales devrait être robuste, reflétant des avancées significatives et un engagement accru sur le marché.

## Segment Insights

### Par Diagnostic & Traitement : Diagnostic (Le Plus Grand) vs. Traitement (Le Plus Rapide Croissant)

Dans le marché des commotions cérébrales, le segment du diagnostic détient actuellement une part significative du marché, grâce aux pratiques et technologies établies utilisées pour identifier les commotions. Les méthodes de diagnostic, y compris les évaluations cliniques et les techniques d'imagerie avancées, sont devenues intégrales dans la gestion des commotions, contribuant à la forte présence sur le marché. En revanche, le segment du traitement, bien que plus petit actuellement, gagne rapidement du terrain à mesure que des thérapies innovantes et des techniques de réhabilitation émergent pour traiter les impacts à long terme des commotions.

Diagnostic : Évaluation Clinique (Dominant) vs. Traitement : Techniques de Réhabilitation (Émergentes)

Le segment du Diagnostic, en particulier les évaluations cliniques, reste dominant sur le marché des commotions cérébrales en raison de son rôle crucial dans la détection précoce et l'intervention. Les protocoles standardisés et les outils d'imagerie avancés améliorent l'efficacité de ces évaluations, garantissant un diagnostic précis. D'autre part, les méthodologies de traitement, en particulier les techniques de réhabilitation, sont dans une phase émergente, caractérisée par leur importance croissante dans la gestion à long terme des commotions. Ce segment évolue, avec une augmentation des plans de traitement personnalisés et des approches multidisciplinaires, montrant un changement vers des soins holistiques à mesure que la sensibilisation aux impacts des commotions augmente.

### Par Utilisateur Final : Hôpitaux et Cliniques (Les Plus Grands) vs. Centres de Diagnostic (Le Plus Rapide Croissant)

Dans le marché des commotions cérébrales, les Hôpitaux et Cliniques détiennent la plus grande part, bénéficiant d'infrastructures établies et de capacités de soins aux patients complètes. Ils ont été essentiels dans le diagnostic et la gestion des cas de commotions en raison de leur accès à des technologies médicales avancées et à une large gamme de spécialistes. Les Centres de Diagnostic, en revanche, augmentent leur empreinte sur le marché en offrant des services spécialisés qui répondent spécifiquement aux évaluations des commotions, attirant ainsi davantage de patients recherchant des diagnostics rapides et précis. Les tendances de croissance indiquent un changement significatif vers l'expansion des Centres de Diagnostic, alimenté par la sensibilisation croissante aux impacts des commotions et la demande d'options d'évaluation et de traitement immédiates. De plus, les Hôpitaux et Cliniques évoluent en intégrant des technologies et des approches de traitement innovantes, ce qui renforce encore leur attrait pour les patients. À mesure que les campagnes de sensibilisation aux commotions se développent et que l'accent sur les blessures à la tête liées au sport augmente, les deux segments sont prêts pour une croissance notable dans les années à venir.

Hôpitaux et Cliniques (Dominants) vs. Centres de Diagnostic (Émergents)

Les Hôpitaux et Cliniques représentent le segment dominant sur le marché des commotions cérébrales, caractérisé par leur approche globale des soins aux patients, y compris des technologies d'imagerie avancées et des équipes multidisciplinaires. Ils offrent une large gamme de services, de l'évaluation initiale à la réhabilitation continue, garantissant ainsi une approche holistique de la gestion des commotions. Les Centres de Diagnostic, bien qu'émergents, gagnent rapidement du terrain en offrant des services ciblés pour le diagnostic des commotions. Ils s'adressent à un marché de niche, fournissant des services rationalisés pour les patients qui nécessitent des évaluations rapides. Avec une reconnaissance croissante de l'importance de la détection précoce et de la gestion, les Centres de Diagnostic tirent parti des outils de diagnostic modernes, ce qui les positionne favorablement dans le paysage des soins de santé.

## Regional Market Share Analysis

By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The North American Concussions Market area will dominate this market, because to the continent's higher prevalence of concussions caused by car accidents and sports injuries, as well as increased government activities and awareness campaigns linked to concussion prevention, diagnosis, and treatment. According to the American Physical Therapy Association (APTA), around 8.6 million sports injuries are documented in this region each year.

Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Europe Concussions Market accounts for the second-largest market share due to rising awareness of the significance of concussions and their potential long-term consequences. Further, the German Concussions Market held the largest market share, and the UK Concussions Market was the fastest growing market in the European region

The Asia-Pacific Concussions Market is expected to grow at the fastest CAGR from 2023 to 2032. This is due to causes such as an older population that is more sensitive to falls, an increase in the number of road accidents, and violence. Moreover, China’s Concussions Market held the largest market share, and the Indian Concussions Market was the fastest growing market in the Asia-Pacific region.

## Competitive Benchmarking

Leading market players are investing heavily in research and development in order to expand their product lines, which will help the Concussions Market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their  footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, Concussionsindustry must offer cost-effective items.
 
Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the  Concussions industry to benefit clients and increase the market sector. In recent years, the Concussions industry has offered some of the most significant advantages to medicine. Major players in the Concussions Market, including Advanced Brain Monitoring, Inc. BioDirection, Inc. BrainScope Company, Inc. InfraScan, Inc, and Nova Signal Corporation,  and others, are attempting to increase market demand by investing in research and development operations.
 
Acorda Therapeutics, Inc. is a biotechnology business headquartered in Pearl River, New York. The company creates medicines to help people with Parkinson's disease, multiple sclerosis, and other neurological illnesses improve their neurological function. In the United States, Acorda Therapeutics develops and markets the medications Inbrija (levodopa inhalation powder) and Ampyra (dalfampridine).  In 2020, Acorda Therapeutics has formed a strategic alliance with the Medical University of South Carolina to develop and commercialize a new concussion therapy.
 
The collaboration planned to use Acorda's neuroscience expertise and the university's experience in concussion research to create new treatment choices for patients. Eli Lilly and corporation is a pharmaceutical corporation based in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in over 125 countries. Colonel Eli Lilly, a pharmaceutical chemist and American Civil War veteran, created and named the corporation in 1876. Colonel Eli Lilly, a pharmaceutical chemist and Union army veteran of the American Civil War, founded the corporation. 
 
Lilly was president of the corporation until his death in 1898. In 2020, Eli Lilly and business announced a collaboration with Imago BioSciences, a biotechnology business, to investigate a viable treatment for concussions. The collaboration planned to use Imago's small molecule inhibitor technology to target the immune system and reduce post-concussion inflammation.

## Recent News & Developments

In March 2026, Northwell Health's North Shore University Hospital, a Level I trauma center, began using Abbott's i-STAT Alinity TBI whole-blood test (measuring GFAP and UCH-L1 biomarkers) in its emergency department to assess suspected concussion/mild TBI in about 15 minutes. It's a real-world clinical adoption milestone (not just a regulatory clearance) showing Abbott's TBI diagnostic moving into high-volume ER settings, reinforcing its lead in the objective concussion-testing segment of the market. (Source: [northwell.edu](https://www.northwell.edu/news/the-latest/northwell-first-in-nys-to-use-traumatic-brain-injury-blood-test))

In December 2025, Medtronic announced U.S. clearance of a new indication for its Onyx Liquid Embolic System — middle meningeal artery embolization as an adjunct to surgery for symptomatic subacute/chronic subdural hematoma — based on the EMBOLISE trial (published in NEJM, Nov 2024), showing ~63% reduction in recurrence/re-operation when combined with surgery. cSDH is a traumatic brain injury commonly caused by head trauma/falls — adjacent to, but distinct from, "concussion" in the strict mTBI sense. I'm flagging this explicitly: it's real, dated, and TBI-related, but it is not a concussion-specific product, so treat it as adjacent-market context rather than a direct concussion-market development. (Source: [news.medtronic.com](https://news.medtronic.com/Medtronic-announces-new-treatment-option-for-chronic-subdural-hematoma-cSDH))

## Report Scope

| MARKET SIZE 2024 | 6.336(USD Billion) |
| --- | --- |
| MARKET SIZE 2025 | 6.691(USD Billion) |
| MARKET SIZE 2035 | 11.54(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.6% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | Abbott Laboratories (US), Medtronic (US), Boston Scientific (US), Stryker Corporation (US), Cortech Solutions (US), Zynex Medical (US), Neurotech Pharmaceuticals (US), Huntleigh Healthcare (GB), B. Braun Melsungen AG (DE) |
| Segments Covered | Diagnosis & Treatment, End-User, Region |
| Key Market Opportunities | Advancements in diagnostic technologies enhance early detection and treatment options in the Concussions Market. |
| Key Market Dynamics | Rising awareness of concussion risks drives demand for advanced diagnostic tools and treatment options in the healthcare sector. |
| Countries Covered | North America, Europe, APAC, South America, MEA |

## Frequently Asked Questions

**Q: Quelle est la valorisation actuelle du marché des commotions cérébrales en 2024 ?**
A: Le marché des commotions cérébrales était évalué à 6,336 milliards USD en 2024.

**Q: Quelle est la taille de marché projetée pour le marché des commotions cérébrales en 2035 ?**
A: Le marché devrait atteindre 11,54 milliards USD d'ici 2035.

**Q: Quel est le CAGR attendu pour le marché des commotions cérébrales pendant la période de prévision 2025 - 2035 ?**
A: Le CAGR attendu pour le marché des commotions cérébrales pendant 2025 - 2035 est de 5,6 %.

**Q: Quels segments sont analysés dans le marché des commotions cérébrales ?**
A: Le marché est segmenté par Diagnostic & Traitement et par Utilisateur final.

**Q: Quelles sont les valeurs projetées pour le segment Diagnostic d'ici 2035 ?**
A: Le segment Diagnostic devrait passer de 2,5 milliards USD à 4,5 milliards USD d'ici 2035.

**Q: Quelle est la valeur attendue pour le segment Traitement d'ici 2035 ?**
A: Le segment Traitement devrait augmenter de 3,836 milliards USD à 7,04 milliards USD d'ici 2035.

**Q: Quelles sont les valorisations attendues pour les hôpitaux et cliniques dans le marché des commotions cérébrales ?**
A: Les hôpitaux et cliniques devraient passer de 2,5 milliards USD à 4,5 milliards USD d'ici 2035.

**Q: Quel rôle jouent des acteurs clés comme Abbott Laboratories et Medtronic sur le marché ?**
A: Des acteurs clés tels qu'Abbott Laboratories et Medtronic sont essentiels pour stimuler l'innovation et la croissance du marché.

**Q: Quelle est la croissance projetée pour les Centres de Diagnostic dans le marché des commotions cérébrales ?**
A: Les Centres de Diagnostic devraient croître de 1,5 milliard USD à 2,5 milliards USD d'ici 2035.

**Q: Comment les payeurs contribuent-ils à la croissance du marché des commotions cérébrales ?**
A: Les payeurs devraient passer de 2,336 milliards USD à 4,54 milliards USD d'ici 2035, indiquant leur importance croissante.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/concussions-market-5724*